The AXA Framlington Biotech Fund is an incredible fund that invests in the health and bio tech sector.
[http://retail.axa-im.co.uk/funds/axa-framlington/axa-framlington-biotech-fund-r-gbp-413/performance]
Year on year performance is amazing.
The Top Ten Holdings are:-
Gilead Sciences
Celgene
Amgen
Biogen Idec
Vertex Pharmaceuticals
Illumina
Alexion Pharmaceuticals
BioMarin Pharmaceutical
Salix Pharmaceuticals
Incyte USA
Today the fund is worth £360m